Servier's Estève Speranza outlines the rationale behind the French group's reorganisation in the Nordic countries, how the global shift towards…

Barbara Fritsche-Surchat outlines Servier's historic commitment to Switzerland, how the French mid-cap's global oncology pivot is translating into its…

The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and Servier lead the way, followed by…

The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…

Morocco has made admirable progress in building a national oncology network in recent years, but the country’s cancer patients still face…

Multinational pharmaceutical companies are increasingly seeing Morocco as a top manufacturing destination for the African continent. Firms from…

Guillaume Recorbet, general manager of Servier in Morocco, explains Servier’s special status in the Moroccan pharma industry as a multinational…

Established in Hungary in 1913, Egis is a traditional Central Eastern European pharmaceutical company with an international footprint across the…

2009 marks 40 years of China’s liberalization and opening up under then-Premier Deng Xiaoping. Servier China also bears the distinction of having…

With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma standard-bearers are once more on the rise. These…

PharmaBoardroom last reported on Thailand in 2015, meeting country managers from across the healthcare and life sciences value chain. Here, we chart…

The latest issue of Healthcare & Life Sciences Review France follows on from our March 2019 report and takes a closer look at the wider French…